EQUALY
Enterprise number 1030343797 · Active (000 Normale toestand)
EQUALY is a naamloze vennootschap registered in Grez-Doiceau, Belgium, incorporated on 13 Nov 2025. Its registered activity is speur- en ontwikkelingswerk op biotechnologisch gebied.
Company details
- Enterprise number
- 1030343797 · official register
- Status
- 000 Normale toestand
- Legal form
- Naamloze vennootschap
- Incorporated
- 13 Nov 2025 (1 years)
- Registered address
- 1390 Grez-Doiceau
- Province
- Walloon Brabant
- Activity
- 72101 Speur- en ontwikkelingswerk op biotechnologisch gebied
- Industry
- Scientific research and development
- Accounts overdue
- No
Insolvency and register events
No insolvency or liquidation events on record.
Similar companies in Walloon Brabant
- "CLINICAL & QUALITY SUPPORT" Villers-la-Ville
- ABAXYS THERAPEUTICS Villers-la-Ville
- ACADEMIC MEDICAL INTERDISCIPLINARY RESEARCH FOUNDATION - RECHERCHE ACADEMIQUE MEDICALE INTERDISCIPLINAIRE FOUNDATION Lasne
- ADBDL Médecine et Sciences médicales Wavre
- ALANINE Lasne
- ALLSIGHTSAFRICA Orp-Jauche
- ANSERS Perwez
- AQYLA BioVenture Builder Wavre
- ARSALIS Genappe
- ART - OS Waterloo
- ARTLINOW Lasne
- ARXIOS Genappe
Questions about EQUALY
What is the enterprise number of EQUALY?
EQUALY is registered under enterprise number 1030343797 in the official register of Belgium. View it at the official register.
Is EQUALY still active?
Yes. EQUALY is registered as active (status: 000 Normale toestand).
Has EQUALY gone bankrupt or into insolvency?
No insolvency, bankruptcy or administration is recorded for EQUALY in the official data.
When was EQUALY founded?
EQUALY was incorporated on 13 Nov 2025.
Where is EQUALY registered?
EQUALY's registered address is in 1390 Grez-Doiceau (Walloon Brabant), Belgium.
Data: FPS Economy – KBO/BCE Open Data (KBO Open Data licence; source: FPS Economy, Crossroads Bank for Enterprises.). National Bank of Belgium – Central Balance Sheet Office web services (NBB-CBSO authentic data, free re-use under the NBB web-service terms.). Last updated 6 Nov 2026.